You are here
Global $2.12 Billion Cell Line Development Markets, 2018-2019 & Forecast to 2024
DUBLIN, April 17, 2019 /PRNewswire/ -- The "Cell Line Development Market - Forecasts from 2019 to 2024" report has been added to ResearchAndMarkets.com's offering.
The global cell line development market is expected to reach US$4.718 billion by 2024 from US$2.122 billion in 2018 growing at a CAGR of 14.24%.
A cell line is a permanently established cell culture that will proliferate indefinitely given appropriate fresh medium and space and are often used in place of primary cells to study biological processes. Cell line development refers to the process of developing stable cell lines for the use in in a number of important applications including biologics (e.g. recombinant protein and monoclonal antibody) production, drug screening, and gene functional studies. The process of cell line development include transfection and selection and single cell cloning.
The market is expected to show a significant growth during the given forecast period owing to the rise in development and demand for monoclonal antibodies around the globe. Rise in vaccine production and technological innovations in cell line development will also augment the growth of the cell line development market. However, strict regulatory framework coupled with the time consuming process for the development of stable lines might restrain the growth of the market during the given time frame.
This research study examines the current market trends related to the demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical region. Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.
Identification of key industry players in the industry and their revenue contribution to the overall business or relevant segment aligned to the study have been covered as a part of competitive intelligence done through extensive secondary research.
Major industry players profiled as part of the report are MabPlex Inc. , ATUM, and Selexis among others.
Key Topics Covered:
1.1. Market Definition
1.2. Scope of the Study
1.5. Base and Forecast Years Timeline
2. Research Methodology
2.1. Research Design
2.2. Secondary Sources
3. Key Findings of the Study
4. Market Dynamics
4.3. Opportunities and Market Trends
4.4. Market Segmentation
4.5. Porter's Five Forces Analysis
4.6. Industry Value Chain Analysis
4.7. Industry Regulations
4.8. Scenario Analysis
5. Global Cell Line Development Market Forecast by Type
5.1. Recombinant Cell Lines
5.3. Continuous Cell Lines
5.4. Primary Cell Lines
6. Global Cell Line Development Market Forecast by Source
6.1. Mammalian Cell Line Development
6.2. Non Mammalian Cell Line Development
7. Global Cell Line Development Market Forecast by Geography
7.1. North America
7.1.1. the U.S
7.2. South America
7.4. Middle East and Africa
7.4.1. Saudi Arabia
7.5. Asia Pacific
7.5.4. South Korea
8. Competitive Intelligence
8.1. Competition and Offerings Analysis of Key Vendors
8.2. Strategies of Key Players
8.3. Recent Investments and Deals
9. Company Profiles
9.3. Wuxi Apptec
9.4. Kbi Biopharma
9.6. Fusion Antibodies Plc
9.8. In Vivo
9.9. Celonic Ag
9.10. Mabplex Inc.
For more information about this report visit https://www.researchandmarkets.com/research/crvqjd/global_2_12?w=5
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets